Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice
NCT04454723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-03-05
Summary
The purpose of this pilot research study is to evaluate the effectiveness of blood and platelet transfusions in improving symptoms and quality of life of patients enrolled in hospice.
Conditions
- Hematologic Malignancy
Interventions
- PROCEDURE
-
Blood and/or platelet transfusion
The transfused patients will receive one unit each of blood and/or platelet transfusions once a week based on CTCAE symptom grade 2 or greater of anemia and/or thrombocytopenia.
- PROCEDURE
-
Complete blood count (CBC) collection
CBC will be collected from patients weekly while on this protocol.
Sponsors & Collaborators
-
University of Oklahoma
lead OTHER
Principal Investigators
-
Jennifer Holter, MD · University of Oklahoma
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-08-14
- Primary Completion
- 2023-08-16
- Completion
- 2023-08-17
Countries
- United States
Study Locations
More Related Trials
-
Red Blood Cell Transfusion Thresholds and QOL in MDS
NCT02099669 ·Status: UNKNOWN ·Phase: NA
-
Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
NCT00068523 ·Status: COMPLETED ·Phase: NA
-
Comparing Fresh Random Platelets and Autologous Cryopreserved Thrombosol Treated Autologous Platelets
NCT00074763 ·Status: TERMINATED ·Phase: PHASE3
-
Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
NCT00005984 ·Status: TERMINATED ·Phase: PHASE2
-
Pilot Study of Unrelated Cord Blood Transplantation
NCT00916045 ·Status: TERMINATED ·Phase: PHASE2
-
A Study for Leukemia Patients With Life-Threatening Infections
NCT00968838 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies
NCT02354417 ·Status: TERMINATED ·Phase: PHASE1
-
Post Transplant Donor Lymphocyte Infusion
NCT00167180 ·Status: TERMINATED ·Phase: PHASE2
-
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
NCT07325253 ·Status: RECRUITING ·Phase: PHASE2
-
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
NCT00004485 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Feasibility Study of Prophylactic White Blood Cell Transfusions
NCT01932710 ·Status: COMPLETED ·Phase: PHASE2
-
Allo HSCT Using RIC and PTCy for Hematological Diseases
NCT05805605 ·Status: RECRUITING ·Phase: PHASE2
-
Eltrombopag Olamine in Increasing Platelet Counts in Patients Undergoing Transplant
NCT01927731 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation
NCT00328237 ·Status: UNKNOWN ·Phase: PHASE2
-
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
NCT00423826 ·Status: NO_LONGER_AVAILABLE
-
Clinical Use of Pathogen Reduced Red Blood Cell Suspension
NCT03426553 ·Status: COMPLETED ·Phase: PHASE3
-
G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
NCT00253552 ·Status: TERMINATED ·Phase: NA
-
Removing Transfusion Dependence as a Barrier to Hospice Enrollment
NCT05063591 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis
NCT00334672 ·Status: UNKNOWN ·Phase: PHASE3
-
Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)
NCT00412360 ·Status: COMPLETED ·Phase: PHASE3
-
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
NCT00544466 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
NCT00453206 ·Status: COMPLETED ·Phase: NA
-
Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00044954 ·Status: COMPLETED ·Phase: PHASE2
-
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
NCT01682226 ·Status: COMPLETED ·Phase: PHASE2
-
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
NCT00054327 ·Status: COMPLETED ·Phase: PHASE2